Literature DB >> 15539934

NF-kappaB, IL-6 and myeloma cell growth: making the connection.

Mark Y Chiang1, Edward A Stadtmauer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15539934     DOI： 10.4161/cbt.3.10.1326

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN： 1538-4047            Impact factor:   4.742


× No keyword cloud information.
  3 in total

1.  Palau'amine and related oroidin alkaloids dibromophakellin and dibromophakellstatin inhibit the human 20S proteasome.

Authors:  Theresa A Lansdell; Nicole M Hewlett; Amanda P Skoumbourdis; Matthew D Fodor; Ian B Seiple; Shun Su; Phil S Baran; Ken S Feldman; Jetze J Tepe
Journal:  J Nat Prod       Date:  2012-05-16       Impact factor: 4.050

2.  Noncompetitive modulation of the proteasome by imidazoline scaffolds overcomes bortezomib resistance and delays MM tumor growth in vivo.

Authors:  Theresa A Lansdell; Michelle A Hurchla; Jingyu Xiang; Stacy Hovde; Katherine N Weilbaecher; R William Henry; Jetze J Tepe
Journal:  ACS Chem Biol       Date:  2012-12-11       Impact factor: 5.100

3.  Interleukin-6 counteracts therapy-induced cellular oxidative stress in multiple myeloma by up-regulating manganese superoxide dismutase.

Authors:  Charles O Brown; Kelley Salem; Brett A Wagner; Soumen Bera; Neeraj Singh; Ajit Tiwari; Amit Choudhury; Garry R Buettner; Apollina Goel
Journal:  Biochem J       Date:  2012-06-15       Impact factor: 3.857
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.